Cancer Heterogeneity and Plasticity

ISSN 2818-7792
Free Publication in 2025

Submit Now
Submit Now
Why Publish with CANCER HETEROG PLAST
  • High Visibility
  • Constructive Peer Review
  • Smooth Editorial Process
  • Permanent Archiving
  • Publication for Free
About This Journal
Cancer Heterogeneity and Plasticity (ISSN 2818-7792) is an international, peer-reviewed, Open Access (OA) journal published quarterly by Pivot Science Publications. It is dedicated to showcasing outstanding original research articles, reviews, and perspectives spanning the dynamic realm of cancer cell heterogeneity and adaptability and the complexities within their microenvironments. Its scope encompasses a wide spectrum of topics, including but not limited to the elucidation of evolutionary relationship of cancer cell subpopulations (i.e., heterogeneity), molecular mechanisms driving cancer cell plasticity (e.g., epithelial-mesenchymal transition or EMT), epigenetic underpinnings of cancer cell reprogramming (e.g., treatment-induced neuroendocrine (NE) transdifferentiation), and the influence of the tumor microenvironment (TME) on cancer cell dynamics. It extends to embrace studies exploring the impact of the microenvironment and systemic host factors (e.g., hormones, growth factors, inflammatory cytokines, and nerves) on cancer progression, therapeutic resistance, cancer cell dissemination and dormancy, metastasis, and the development of innovative targeted and combinatorial therapies.
Read more >
About Editor-in-Chief
Dean G. Tang

Distinguished Professor and Chair, Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center (RPCCC), USA

Dean Tang, PhD, is currently Distinguished Professor and Chair of Department of Pharmacology & Therapeutics at the Roswell Park Comprehensive Cancer Center in Buffalo, NY. He also holds the George Decker Endowed Chair in Developmental Therapeutics. Trained as a Pathologist, Dr. Tang obtained his PhD in Cancer Biology in 1994 from Wayne State University (Detroit, MI, USA). In 1998-2000, Dean pursued a Burroughs-Wellcome senior post-doctoral fellowship with Dr. Martin Raff at the MRC LMCB (University College London, UK) studying stem/progenitor cell development and plasticity. In June 2000, Dr. Tang joined the University of Texas M.D Anderson Cancer Center as a faculty member. After working at the M.D Anderson for 16 years, Dr. Tang was recruited to Roswell Park in June of 2016 to Chair the Department of Pharmacology & Therapeutics and Co-Lead the CCSG Developmental Therapeutic (DT) Program. He’s also the Chair of the Experimental Therapeutic (ET) Graduate Program. 
Read more >
Latest Articles
Review

Stem Cell Plasticity Fuels Intratumoral Niche Dynamics in Glioblastoma

Evan Joseph, Lilly J. Speier, Christopher G. Hubert

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502030012

Received: May 1, 2025 | Accepted: Jul 6, 2025 | Published: Jul 17, 2025
Review

Microenvironmental Regulation of Colorectal Cancer Stemness: Technological Advances, Molecular Basis, and Therapeutic Targets

Hui Zhao, Qilin Li, Jichao Qin

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502020011

Received: Nov 28, 2024 | Accepted: Jun 18, 2025 | Published: Jun 26, 2025
Review

Inner and Outer Determinants of Pancreatic Cancer Stem Cells

Juan Carlos López-Gil, Diego Navarro, Bruno Sainz, Jr.

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502020010

Received: Apr 15, 2025 | Accepted: May 30, 2025 | Published: Jun 16, 2025
Commentary

Luminal Transcription Factor Hierarchy Shapes the AR Cistrome in Prostate Cancer

Ishana Lodhia, Amina Zoubeidi

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502020009

Received: May 7, 2025 | Accepted: May 12, 2025 | Published: May 22, 2025
Original Research

A Hierarchy of Luminal Transcription Factors Defines AR Cistrome and Is Lost in Neuroendocrine Prostate Cancer

Viriya Keo, Xiaodong Lu, Lourdes Brea, Xianglin Shi, Jindan Yu, Jonathan C. Zhao

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502020008

Received: Dec 6, 2024 | Accepted: Apr 16, 2025 | Published: May 6, 2025
Original Research

Combined Transcriptomic and Epitranscriptomic Profiling Identifies THBS1 as A Regulator of Enzalutamide Resistance in Prostate Cancer

Emmanuelle Hodara, Lisa Swartz, Aubree Mades, Daniel Bsteh, Tong Xu, Suhn K. Rhie, Amir Goldkorn

Cancer Heterogeneity and Plasticity https://doi.org/10.47248/chp2502020007

Received: Dec 14, 2024 | Accepted: Apr 3, 2025 | Published: Apr 21, 2025
Read More >

About Us Journals Join Us Submit Fees Contact

Copyright © 2025 Pivot Science Publications Corp. - unless otherwise stated | Terms and Conditions | Privacy Policy